LABDvsRXD
DIREXION DAILY S&P BIOTECH BEAR 3X SHARES against ProShares UltraShort Health Care — the fee, the flows, the book, and a year head-to-head.
Head to head
| LABD | RXD | |
|---|---|---|
| Expense ratio | — | 0.95% |
| Assets | $138M | $3137.79T |
| Net flow, 1 month | +$55M | +$140 |
| Net flow, 1 year | +$183M | +$3K |
| Return, YTD | -64.4% | -15.5% |
| Return, 1 year | -80.1% | -28.0% |
| Avg daily volume | 21.9M | 9K |
| Holdings | 1 | 8 |
| Listed | Jul 31, 2024 | Feb 1, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS